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CASE REPORT
A	 28	 year-old	 male	 presented	 for	 evaluation	
and excision of multiple papules that had been ap-
pearing progressively over the previous 3 years. Phys-
ical	 examination	 revealed	 soft,	flesh-colored	papules	
and	nodules,	distributed	in	dermatomal	fashion	from	
the left chest wall anteriorly to the back posteriorly 
(Figure	1).	The	 lesions	did	not	cross	 the	median	 line	
and	no	axillary	 freckles	or	 café-au-lait	macules	were	
seen. There was no positive family history. The histo-
pathological examination revealed a non-encapsulat-
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Figure 1: 
Lesions appearing in 
dermatomal fashion on 
the anterior chest wall 
and back
ed,	 well-circumscribed	 spindle	 cell	 neoplasm,	 with	
cells	 arranged	 in	 fascicles	 (spindle	 to	wavy),	 as	well	
as	 buckled	 nuclei,	 indistinct	 cytoplasm	 and	myxoid	
background,	 consistent	 with	 neurofibromas	 (Figure	
2).	The	patient	was	diagnosed	with	segmental	neuro-
fibromatosis	(SNF)	and	examined	at	the	ophtalmology	
department,	ruling	out	ocular	disease.	Magnetic	reso-
nance	imaging	showed	no	bone,	central	or	peripheral	
nervous system abnormalities.
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DISCUSSION
Neurofibromatosis	 (NF)	 is	 extremely	 variable	
in	 its	 presentation.	 Segmental	 neurofibromatosis	
(SNF)	 is	 a	 rare	 disorder	 (prevalence	 between	 0.0014	
and	0.002%)	characterized	by	café-au-lait	spots	and/
or	neurofibromas	in	a	single,	unilateral	segment	of	the	
body.	It	does	not	entail	crossing	of	the	median	line,	sys-
temic	involvement,	or	family	history.1,2	Furthermore,	it	
may	go	unrecognized	if	few	lesions	are	observed.
First	described	in	1956,	SNF	was	initially	termed	
sectorial	NF.	In	1982,	Riccardi	included	SNF	in	his	NF	
classification	 to	 represent	 NF	 type	 5.3,4 It is thought 
to	arise	from	a	postzygotic	NF	type	1	gene	mutation	
located	on	the	proximal	long	arm	of	chromosome	17,	
and may occur in both somatic and gonadal cell lines. 
Patients	whose	manifestations	are	limited	to	neurofi-
bromas are believed to carry the mutation in Schwann 
cells	(explaining	its	dermatomal	distribution).	If	only	
pigmentary	manifestations	are	present,	 the	mutation	
occurs	 in	 the	 fibroblasts	 (explaining	 the	 blaschcoid	
distribution).	Gonadal	mosaicism	is	thought	to	be	re-
sponsible	for	localized	disease	in	patients	whose	chil-
dren	have	generalized	NF	type	1.5	Clinically,	it	presents	
solely	 with	 pigmentary	 changes	 or	 neurofibromas,	
with	 both	 pigmentary	 changes	 and	 neurofibromas,	
also	 with	 both	 pigmentary	 changes	 and	 neurofibro-
mas,	and	with	isolated	plexiform	neurofibromas.	Most	
commonly,	patients	only	present	with	mainly	cervical	
or	thoracic	neurofibromas.3	In	rarer	cases,	the	face	may	
be the only affected site.6 Systemic complications typ-
ically associated with NF type 1 are rare (under 10% 
of	cases)	and	 include:	 learning	difficulties,	plexiform	
neurofibromas,	optic	pathway	gliomas	and	pseudar-
throsis.1 It has been proposed that the risk of malig-
nancy in SNF may be comparable to NF type1 and 
therefore,	age-appropriate	malignancy	screening	is	in-
dicated. Individuals with SNF have a low risk of trans-
mitting	the	disease	to	their	offspring,	although	genetic	
counseling and evaluation of offspring for NF skin 
lesions and cognitive impairment are advisable.5 SNF 
may be underreported since it is almost asymptomatic 
and patients only seek medical attention for cosmetic 
concerns. Physicians must be vigilant and able to rec-
ognize	and	manage	the	condition.q
Figure 2:	A.	Proliferation	of	dermal,	non-encapsulated	spindle	cells	
(Hematoxylin-eosin;	X2).	B.	Spindle	 cells	with	wavy	nuclei,	 inter-
spersed	in	a	stroma	of	fibrillary	collagen.	No	nuclear	pleomorphism	
or	mitoses	were	seen	(Hematoxylin-eosin;	X40)
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Abstract:	Neurofibromatosis	is	extremely	variable	in	its	presentation.	Segmental	neurofibromatosis	(SNF),	which	
corresponds	to	NF-type	5	in	the	Riccardi	classification,	is	a	rare	disorder.	It	may	go	unrecognized	if	few	lesions	are	
observed.	We	present	a	case	of	segmental	neurofibromatosis	in	a	28	year-old	patient	who	presented	with	multiple	
papules and nodules distributed in dermatomal fashion on the trunk. The histopathological examination of the 
lesions	revealed	a	non-encapsulated,	well-circumscribed	spindle	cell	neoplasm,	which	was	consistent	with	neu-
rofibromas.
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